The following guideline can be ordered through the address listed in the "Source/Publisher"-category. In cases in which you can order through the Internet we have established a hyperlink.

Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus


FDA Office of Communication, Outreach and Development (OCOD), 10903 New Hampshire Ave., Bldg. 71, Rm. 3128, Silver Spring,

Document Type:
Draft Guidance for Industry
Currently, certain hepatitis C virus (HCV) nucleic acid tests (NAT) licensed for donor screening are also licensed for use as a supplemental test to confirm HCV infection for specimens that are repeatedly reactive on a licensed donor screening test for anti-HCV.

Go back

GMP Conferences by Topics